• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

作者信息

Miyagi Y, Koshikawa N, Yasumitsu H, Miyagi E, Hirahara F, Aoki I, Misugi K, Umeda M, Miyazaki K

机构信息

Department of Pathology, Yokohama City University School of Medicine, Kanagawa.

出版信息

J Biochem. 1994 Nov;116(5):939-42. doi: 10.1093/oxfordjournals.jbchem.a124648.

DOI:10.1093/oxfordjournals.jbchem.a124648
PMID:7896752
Abstract

A serine proteinase inhibitor was purified from conditioned medium of the human glioblastoma cell line T98G. Analysis of its partial amino acid sequences indicated that this protein was identical to placental protein 5 (PP5), a placenta-derived glycoprotein with serine proteinase inhibitor activity, the amino acid sequence of which had been partially determined. cDNA cloning of PP5 demonstrated that it belonged to the Kunitz-type serine proteinase inhibitor family, having three putative Kunitz-type inhibitor domains, and that it was identical to a recently reported inhibitor, tissue factor pathway inhibitor-2 (TFPI-2) [Sprecher et al. (1994) Proc. Natl. Acad. Sci. USA 91, 3353-3357]. PP5/TFPI-2 transcripts were highly abundant in the full-term placenta and widely expressed in various adult human tissues, such as the liver, skeletal muscle, heart, kidney, and pancreas. Several ovarian carcinoma cells as well as T98G also contained significant amounts of the transcripts.

摘要

相似文献

1
cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.
J Biochem. 1994 Nov;116(5):939-42. doi: 10.1093/oxfordjournals.jbchem.a124648.
2
Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization.原位杂交显示人胎盘合体滋养层细胞中PP5/TFPI2 mRNA的特异性表达。
Placenta. 1998 Mar-Apr;19(2-3):217-23. doi: 10.1016/s0143-4004(98)90011-x.
3
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.一种与组织因子途径抑制剂同源的新型人Kunitz型蛋白酶抑制剂的抑制特性
Biochemistry. 1996 Jan 9;35(1):266-72. doi: 10.1021/bi951501d.
4
Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6.编码小鼠PP5/TFPI-2的cDNA的克隆及该基因在6号染色体上的定位。
DNA Cell Biol. 1996 Nov;15(11):947-54. doi: 10.1089/dna.1996.15.947.
5
Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.丝氨酸蛋白酶抑制剂PP5/TFPI-2/MSPI的表达在体外和体内均可降低人绒毛膜癌细胞的侵袭能力。
Gynecol Oncol. 2001 Nov;83(2):325-33. doi: 10.1006/gyno.2001.6394.
6
Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene.人类组织因子途径抑制物-2基因的基因组结构与启动子活性
Biochim Biophys Acta. 2001 Feb 16;1517(3):430-5. doi: 10.1016/s0167-4781(00)00298-0.
7
Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.第二种人组织因子途径抑制剂的分子克隆、表达及部分特性分析
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3353-7. doi: 10.1073/pnas.91.8.3353.
8
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.细胞外基质相关丝氨酸蛋白酶抑制剂(分子量33,000、31,000和27,000)是具有不同糖基化的单基因产物:33-kDa抑制剂的cDNA克隆揭示其与组织因子途径抑制剂-2相同。
Arch Biochem Biophys. 1996 Nov 1;335(1):82-92. doi: 10.1006/abbi.1996.0484.
9
Purification and identification of a novel and four known serine proteinase inhibitors secreted by human glioblastoma cells.人胶质母细胞瘤细胞分泌的一种新型和四种已知丝氨酸蛋白酶抑制剂的纯化与鉴定
J Biochem. 1996 Feb;119(2):334-9. doi: 10.1093/oxfordjournals.jbchem.a021244.
10
Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains.
J Biol Chem. 1997 May 2;272(18):12202-8. doi: 10.1074/jbc.272.18.12202.

引用本文的文献

1
Reassessing the Role of Tissue Factor Pathway Inhibitor 2 in Neoplastic and Non-Neoplastic Lesions.重新评估组织因子途径抑制物2在肿瘤性和非肿瘤性病变中的作用
Cancers (Basel). 2025 Apr 25;17(9):1447. doi: 10.3390/cancers17091447.
2
Assessment of tissue factor pathway inhibitor 2 (TFPI2) as a novel serum marker for malignant tumors of the ovary before and after treatment: A case-control study.评估组织因子途径抑制剂2(TFPI2)作为卵巢恶性肿瘤治疗前后的新型血清标志物:一项病例对照研究。
J Obstet Gynaecol Res. 2025 Feb;51(2):e16241. doi: 10.1111/jog.16241.
3
Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma.
组织因子途径抑制剂 2(TFPI2)是透明细胞肾细胞癌的一种潜在血清生物标志物。
Sci Rep. 2024 Nov 19;14(1):28639. doi: 10.1038/s41598-024-80248-x.
4
Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study.组织因子途径抑制剂 2 作为子宫内膜癌的血清生物标志物:一项单中心回顾性研究。
BMC Cancer. 2024 Aug 27;24(1):1058. doi: 10.1186/s12885-024-12827-0.
5
Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis.组织因子途径抑制剂-2(TFPI-2)——在癌症和转移中被低估的参与者。
Cancer Metastasis Rev. 2024 Dec;43(4):1185-1204. doi: 10.1007/s10555-024-10205-7. Epub 2024 Aug 17.
6
Specific expression and blood kinetics for relaxin 2, lipocalin 2, and tissue factor pathway inhibitor 2 at the canine placenta and pregnant bloods.犬胎盘和妊娠血液中松弛素 2、脂联素 2 和组织因子途径抑制物 2 的特异性表达和血液动力学。
J Vet Med Sci. 2024 Jan 26;86(1):77-86. doi: 10.1292/jvms.23-0241. Epub 2023 Dec 6.
7
Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer.术前血清组织因子途径抑制物-2水平作为子宫内膜癌的预后标志物
Oncol Lett. 2023 Sep 13;26(5):463. doi: 10.3892/ol.2023.14050. eCollection 2023 Nov.
8
Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia.组织因子途径抑制剂作为理解子痫前期病理生理学的潜在靶点。
Biomedicines. 2023 Apr 22;11(5):1237. doi: 10.3390/biomedicines11051237.
9
Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.肿瘤微环境的物理化学特性作为血管生成拟态的驱动因素。
Cancer Metastasis Rev. 2022 Dec;41(4):935-951. doi: 10.1007/s10555-022-10067-x. Epub 2022 Oct 13.
10
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.组织因子途径抑制剂 2 作为卵巢透明细胞癌术前预测的特异性生物标志物的验证。
Int J Clin Oncol. 2021 Jul;26(7):1336-1344. doi: 10.1007/s10147-021-01914-y. Epub 2021 May 19.